| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,500 |
22,787 |
$1.69M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,483 |
17,777 |
$925K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,834 |
5,713 |
$192K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,953 |
1,928 |
$131K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,417 |
1,391 |
$98K |
| X5622 |
|
2,760 |
2,686 |
$96K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,119 |
1,081 |
$87K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,321 |
1,286 |
$81K |
| 36415 |
Collection of venous blood by venipuncture |
18,481 |
16,941 |
$61K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
8,616 |
8,455 |
$60K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,511 |
3,406 |
$47K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,241 |
1,200 |
$41K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,222 |
1,181 |
$40K |
| 80061 |
Lipid panel |
3,056 |
2,983 |
$37K |
| 80053 |
Comprehensive metabolic panel |
3,439 |
3,362 |
$32K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
426 |
417 |
$31K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
380 |
374 |
$30K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,444 |
3,345 |
$28K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
414 |
391 |
$27K |
| 90686 |
|
4,264 |
4,160 |
$27K |
| 92551 |
|
4,211 |
4,131 |
$27K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,049 |
1,016 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,060 |
3,856 |
$24K |
| 92015 |
Determination of refractive state |
1,952 |
1,909 |
$23K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
290 |
281 |
$23K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
462 |
431 |
$19K |
| 84443 |
Thyroid stimulating hormone (TSH) |
932 |
908 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
341 |
332 |
$13K |
| 81514 |
|
52 |
52 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,755 |
1,661 |
$12K |
| 99188 |
|
1,677 |
1,666 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
782 |
739 |
$11K |
| 87481 |
|
271 |
258 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
314 |
292 |
$9K |
| 80050 |
General health panel |
161 |
161 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
340 |
331 |
$8K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
189 |
185 |
$8K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
228 |
219 |
$8K |
| 86780 |
|
515 |
504 |
$7K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
71 |
69 |
$7K |
| 86803 |
|
422 |
415 |
$6K |
| 90651 |
|
218 |
215 |
$5K |
| 85027 |
|
911 |
895 |
$5K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
198 |
192 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
677 |
649 |
$5K |
| 99173 |
|
3,517 |
3,446 |
$5K |
| 99215 |
Prolong outpt/office vis |
65 |
63 |
$4K |
| 87660 |
|
205 |
194 |
$4K |
| 87510 |
|
205 |
194 |
$4K |
| 87480 |
|
204 |
193 |
$4K |
| 90715 |
|
363 |
344 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
490 |
464 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
375 |
335 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
619 |
616 |
$4K |
| 90670 |
|
937 |
924 |
$4K |
| 81001 |
|
1,309 |
1,227 |
$3K |
| 0064A |
|
71 |
66 |
$2K |
| 96127 |
|
633 |
618 |
$2K |
| 90656 |
|
252 |
251 |
$2K |
| 90480 |
|
87 |
87 |
$2K |
| 81025 |
|
380 |
358 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
42 |
41 |
$2K |
| 0134A |
|
44 |
44 |
$1K |
| 0011A |
|
31 |
31 |
$1K |
| 85018 |
|
736 |
718 |
$1K |
| 90834 |
Psychotherapy, 45 minutes with patient |
94 |
63 |
$1K |
| 0012A |
|
38 |
38 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
228 |
226 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
135 |
129 |
$1K |
| 82728 |
|
87 |
87 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
31 |
29 |
$1K |
| 99177 |
|
185 |
185 |
$1K |
| 90832 |
Psychotherapy, 30 minutes with patient |
25 |
24 |
$1K |
| 87081 |
|
615 |
592 |
$1K |
| 36416 |
|
423 |
381 |
$910.60 |
| 91322 |
|
12 |
12 |
$767.92 |
| 83735 |
|
136 |
128 |
$753.40 |
| 90653 |
|
39 |
39 |
$657.00 |
| 87340 |
|
64 |
62 |
$653.46 |
| 90694 |
|
38 |
38 |
$528.00 |
| 99000 |
|
141 |
131 |
$525.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12 |
12 |
$407.86 |
| 87210 |
|
137 |
130 |
$344.51 |
| 83655 |
|
12 |
12 |
$325.44 |
| 90707 |
|
216 |
211 |
$323.80 |
| 90716 |
|
292 |
286 |
$304.56 |
| 96380 |
|
19 |
18 |
$294.28 |
| 86850 |
|
31 |
31 |
$265.60 |
| 86787 |
|
18 |
18 |
$234.26 |
| 86762 |
|
18 |
18 |
$231.75 |
| 82607 |
|
15 |
15 |
$225.26 |
| 82248 |
|
44 |
44 |
$214.02 |
| 87467 |
|
18 |
18 |
$190.28 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
12 |
12 |
$189.27 |
| 90734 |
|
141 |
136 |
$164.59 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
108 |
97 |
$162.03 |
| 93000 |
|
27 |
27 |
$128.50 |
| 82950 |
|
14 |
14 |
$62.66 |
| 86900 |
|
19 |
19 |
$51.16 |
| 86901 |
|
19 |
19 |
$51.16 |
| 81003 |
|
51 |
51 |
$17.82 |
| 90681 |
|
130 |
115 |
$0.00 |
| 90633 |
|
276 |
267 |
$0.00 |
| 91321 |
|
16 |
16 |
$0.00 |
| 90647 |
|
636 |
612 |
$0.00 |
| 90677 |
|
173 |
170 |
$0.00 |
| 90723 |
|
668 |
636 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
45 |
44 |
$0.00 |
| 90696 |
|
34 |
34 |
$0.00 |
| 90381 |
|
19 |
19 |
$0.00 |